Tianjin Pharmaceutical Da Ren Tang Group Limited (600329.SHG) Q2 2024 Earnings

29AprConfirmed
Aug 22
Oct 22
Q1 2023
Q2 2024
0.17
0.23
0.29
0.35

Details

Expected EPS
N/A
Actual EPS
N/A
Surprise EPS
0
Surprise Percent
+NaN%

Description

Tianjin Pharmaceutical Da Ren Tang Group Limited (600329.SHG) will report earnings of for Q2 2024 on April 29, 2024.

0 Comments

Share your thoughts